Hysteroscopic resection of a uterine caesarean scar defect (niche) in women with postmenstrual spotting: a randomised controlled trial

Ajmw Vervoort, L F van der Voet, Wjk Hehenkamp, A L Thurkow, Pjm van Kesteren, H Quartero, W Kuchenbecker, M Bongers, P Geomini, Lhm de Vleeschouwer, Mha van Hooff, H van Vliet, S Veersema, W B Renes, K Oude Rengerink, S E Zwolsman, Ham Brölmann, Bwj Mol, Jaf Huirne, Ajmw Vervoort, L F van der Voet, Wjk Hehenkamp, A L Thurkow, Pjm van Kesteren, H Quartero, W Kuchenbecker, M Bongers, P Geomini, Lhm de Vleeschouwer, Mha van Hooff, H van Vliet, S Veersema, W B Renes, K Oude Rengerink, S E Zwolsman, Ham Brölmann, Bwj Mol, Jaf Huirne

Abstract

Objective: To compare the effectiveness of a hysteroscopic niche resection versus no treatment in women with postmenstrual spotting and a uterine caesarean scar defect.

Design: Multicentre randomised controlled trial.

Setting: Eleven hospitals collaborating in a consortium for women's health research in the Netherlands.

Population: Women reporting postmenstrual spotting after a caesarean section who had a niche with a residual myometrium of ≥3 mm, measured during sonohysterography.

Methods: Women were randomly allocated to hysteroscopic niche resection or expectant management for 6 months.

Main outcome measures: The primary outcome was the number of days of postmenstrual spotting 6 months after randomisation. Secondary outcomes were spotting at the end of menstruation, intermenstrual spotting, dysuria, sonographic niche measurements, surgical parameters, quality of life, women's satisfaction, sexual function, and additional therapy. Outcomes were measured at 3 months and, except for niche measurements, also at 6 months after randomisation.

Results: We randomised 52 women to hysteroscopic niche resection and 51 women to expectant management. The median number of days of postmenstrual spotting at baseline was 8 days in both groups. At 6 months after randomisation, the median number of days of postmenstrual spotting was 4 days (interquartile range, IQR 2-7 days) in the intervention group and 7 days (IQR 3-10 days) in the control group (P = 0.04); on a scale of 0-10, discomfort as a result of spotting had a median score of 2 (IQR 0-7) in the intervention group, compared with 7 (IQR 0-8) in the control group (P = 0.02).

Conclusions: In women with a niche with a residual myometrium of ≥3 mm, hysteroscopic niche resection reduced postmenstrual spotting and spotting-related discomfort.

Tweetable abstract: A hysteroscopic niche resection is an effective treatment to reduce niche-related spotting.

Keywords: Abnormal uterine bleeding; caesarean section; hysteroscopic resection; niche; postmenstrual spotting.

© 2017 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.

Figures

Figure 1
Figure 1
Hysteroscopic niche resection: (A) hysteroscopic view of the niche, with lower rim visible; (B) resection of the lower rim using a resectoscope; (C) coagulation of the niche surface using a rollerball; (D) hysteroscopic view on the site of the niche after the resection.
Figure 2
Figure 2
Flow chart.

References

    1. Bij de Vaate AJ, Brolmann HA, van der Voet LF, van der Slikke JW, Veersema S, Huirne JA. Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting. Ultrasound Obstet Gynecol 2011;37:93–9.
    1. Bij de Vaate AJ, van der Voet LF, Naji O, Witmer M, Veersema S, Brolmann HA, et al. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol 2014;43:372–82.
    1. van der Voet LF, Bij de Vaate AM, Veersema S, Brolmann HA, Huirne JA. Long‐term complications of caesarean section. The niche in the scar: a prospective cohort study on niche prevalence and its relation to abnormal uterine bleeding. BJOG 2014;121:236–44.
    1. Fabres C, Aviles G, De La Jara C, Escalona J, Munoz JF, Mackenna A, et al. The cesarean delivery scar pouch: clinical implications and diagnostic correlation between transvaginal sonography and hysteroscopy. J Ultrasound Med 2003;22:695–700.
    1. Thurmond AS, Harvey WJ, Smith SA. Cesarean section scar as a cause of abnormal vaginal bleeding: diagnosis by sonohysterography. J Ultrasound Med 1999;18:13–16.
    1. Wang CB, Chiu WW, Lee CY, Sun YL, Lin YH, Tseng CJ. Cesarean scar defect: correlation between Cesarean section number, defect size, clinical symptoms and uterine position. Ultrasound Obstet Gynecol 2009;34:85–9.
    1. Erickson SS, Van Voorhis BJ. Intermenstrual bleeding secondary to cesarean scar diverticuli: report of three cases. Obstet Gynecol 1999;93:802–5.
    1. Van HA, Temmerman M, Dhont M. Cesarean scar dehiscence and irregular uterine bleeding. Obstet Gynecol 2003;102:1137–9.
    1. Monteagudo A, Carreno C, Timor‐Tritsch IE. Saline infusion sonohysterography in nonpregnant women with previous cesarean delivery: the “niche” in the scar. J Ultrasound Med 2001;20:1105–15.
    1. Osser OV, Jokubkiene L, Valentin L. Cesarean section scar defects: agreement between transvaginal sonographic findings with and without saline contrast enhancement. Ultrasound Obstet Gynecol 2010;35:75–83.
    1. Valenzano MM, Mistrangelo E, Lijoi D, Fortunato T, Lantieri PB, Risso D, et al. Transvaginal sonohysterographic evaluation of uterine malformations. Eur J Obstet Gynecol Reprod Biol 2006;124:246–9.
    1. Osser OV, Jokubkiene L, Valentin L. High prevalence of defects in Cesarean section scars at transvaginal ultrasound examination. Ultrasound Obstet Gynecol 2009;34:90–7.
    1. van der Voet LF, Vervoort AJ, Veersema S, BijdeVaate AJ, Brolmann HA, Huirne JA. Minimally invasive therapy for gynaecological symptoms related to a niche in the caesarean scar: a systematic review. BJOG 2014;121:145–56.
    1. Fabres C, Arriagada P, Fernandez C, Mackenna A, Zegers F, Fernandez E. Surgical treatment and follow‐up of women with intermenstrual bleeding due to cesarean section scar defect. J Minim Invasive Gynecol 2005;12:25–8.
    1. Feng YL, Li MX, Liang XQ, Li XM. Hysteroscopic treatment of postcesarean scar defect. J Minim Invasive Gynecol 2012;19:498–502.
    1. Wang CJ, Huang HJ, Chao A, Lin YP, Pan YJ, Horng SG. Challenges in the transvaginal management of abnormal uterine bleeding secondary to cesarean section scar defect. Eur J Obstet Gynecol Reprod Biol 2011;154:218–22.
    1. Chang Y, Tsai EM, Long CY, Lee CL, Kay N. Resectoscopic treatment combined with sonohysterographic evaluation of women with postmenstrual bleeding as a result of previous cesarean delivery scar defects. Am J Obstet Gynecol 2009;200:370–4.
    1. Florio P, Gubbini G, Marra E, Dores D, Nascetti D, Bruni L, et al. A retrospective case‐control study comparing hysteroscopic resection versus hormonal modulation in treating menstrual disorders due to isthmocele. Gynecol Endocrinol 2011;27:434–8.
    1. Gubbini G, Casadio P, Marra E. Resectoscopic correction of the “isthmocele” in women with postmenstrual abnormal uterine bleeding and secondary infertility. J Minim Invasive Gynecol 2008;15:172–5.
    1. Gubbini G, Centini G, Nascetti D, Marra E, Moncini I, Bruni L, et al. Surgical hysteroscopic treatment of cesarean‐induced isthmocele in restoring fertility: prospective study. J Minim Invasive Gynecol 2011;18:234–7.
    1. Marra E. Resectoscopic treatment of “Isthmocele”: “Isthmoplasty”. In: P C, F A, D DA, M B, MA R, editors.: Gynaecol Surg; 2009. p. S108‐S9.
    1. Li C, Guo Y, Liu Y, Cheng J, Zhang W. Hysteroscopic and laparoscopic management of uterine defects on previous cesarean delivery scars. J Perinat Med 2014;42:363–70.
    1. Raimondo G, Grifone G, Raimondo D, Seracchioli R, Scambia G, Masciullo V. Hysteroscopic treatment of symptomatic cesarean‐induced isthmocele: a prospective study. J Minim Invasive Gynecol 2015;22:297–301.
    1. Vervoort AJ, van der Voet LF, Witmer M, Thurkow AL, Radder CM, van Kesteren PJ, et al. The HysNiche trial: hysteroscopic resection of uterine caesarean scar defect (niche) in patients with abnormal bleeding, a randomised controlled trial. BMC Womens Health 2015;15:103.
    1. Maarse M, BijdeVaate AJM, Huirne JAF, Brölmann HAM. De maandkalender; een hulpmiddel voor een efficiënte menstruatieanamnese. NTOG 2012;124:231–6.
    1. Ware JE Jr, Sherbourne CD. The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
    1. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108.
    1. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self‐report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208.
    1. Naji O, Abdallah Y, Bij de Vaate AJ, Smith A, Pexsters A, Stalder C, et al. Standardized approach for imaging and measuring Cesarean section scars using ultrasonography. Ultrasound Obstet Gynecol 2012;39:252–9.
    1. Berthelot JM, Le GB, Maugars Y. The Hawthorne effect: stronger than the placebo effect? Joint Bone Spine 2011;78:335–6.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit